A right hepatic (RH) graft without the middle hepatic vein (MHV) trunk used in living donor liver transplantation (LDLT) often has multiple venous orifices which should be rigorously reconstructed in order to avoid detrimental graft congestion in most cases. These venous orifices are the outlet of the superior right hepatic vein (SRHV) which is the largest venous orifice on a right graft, the one of the inferior right hepatic vein (IRHV), the one of the segment 5 tributary veins (V5s) of the MHV, and the one of the segment 8 tributary veins (V8s) of the MHV. Various means of reconstructing these venous orifices-the use of synthetic artificial grafts, explanted portal vein (EPV) grafts, cryopreserved veins, superficial femoral veins, and so on-have been reported so far. (1, 2) Each reconstruction method has its own merits and drawbacks. However, the most reliable one keeping the patency of these reconstructing veins high should be selected because the obstruction of these veins may lead to severe congestion of graft livers and thus deteriorating liver function leading to septic complications. In our history, there were some limitations on the use of autologous explant portal vein grafts for reconstructing venous orifices; thus, we began to use internal jugular vein (IJV) grafts for such reconstructions. In our history, there were some limitations on the use of autologous explant portal vein grafts for reconstructing venous orifices; thus, we began to use internal jugular vein (IJV) grafts for such reconstructions. Then, we aggressively used IJV grafts which were often combined with other autologous vascular grafts for reconstructing these venous orifices because we proposed that they were not only the most viable but also the most flexible vascular conduit among the various vascular grafts reported so far. (3) The aim of the current study was to retrospectively investigate the efficacy of using IJV grafts for reconstructing multiple venous orifices on RH grafts without the MHV trunk.
Methods

DEFINITIONS OF THE VENOUS ORIFICES ON A RH GRAFT
We defined each venous orifice in the current study as follows: an orifice of the large vein located at the upper portion of a RH graft and usually called the RH vein was defined as the SRHV orifice. The SRHV was the main drainage vein in a RH graft. An orifice of the vein directly connected to the inferior vena cava (IVC) and located below the SRHV orifice was defined as the IRHV orifice. Some grafts had multiple IRHV orifices. An orifice of the vein whose drainage territory was mainly the Couinaud's segment 8 and drained into the MHV trunk was defined as the V8 orifice. Some grafts had multiple V8 orifices. An orifice of the vein whose drainage territory was mainly the Couinaud's segment 5 and drained into the MHV trunk was defined as the V5 orifice. Some grafts also had multiple V5 orifices.
PATIENTS
Data were retrospectively obtained from the medical records of 174 recipients who underwent LDLT between January 2004 and July 2015 using a RH graft without the trunk of the MHV in our institute. All LDLTs were performed after obtaining approval from the ethics and indications committee for LDLT in our institute. The study was approved by the institutional review board of Kyushu University (No. 27-303). The recipients were divided into the following 3 groups according to how the venous orifices were reconstructed. Group 1 consisted of recipients in whom only the SRHV was reconstructed or the SRHV and the IRHVs were reconstructed by direct anastomoses to the IVC (no vascular graft group; n 5 45). Some SRHVs were tailored to have a vascular flap on the anterior wall for easy anastomosis. Group 2 consisted of recipients in whom the multiple venous orifices were reconstructed using an IJV graft only or an IJV graft combined with other vascular grafts (IJV graft group; n 5 56). Representative schematic diagrams of reconstructing multiple venous orifices are depicted in Fig.  1 . Group 3 consisted of recipients in whom the multiple venous orifices were reconstructed using vascular grafts other than an IJV graft (vascular graft other than IJV group; n 5 73). Procurement of an IJV graft was performed as previously described. (3) Our surgical techniques and perioperative managements were the same as previously described. (4) Venous orifices of >5 mm on contrast-enhanced computed tomography (CT) were subject to reconstruction. How the venous orifices were reconstructed or whether an IJV graft was used or not in each recipient was mainly at the discretion of the respective attending surgeons. Some IRHVs were directly anastomosed to the IVC. Patency of each reconstructed vein was evaluated by contrastenhanced CT examinations in order to make objective judgments. CT examinations were taken around on postoperative day 7 as a routine workup, and thereafter according to individual patients' need. Some patients did not undergo any contrast-enhanced CT examination because of their impaired renal function. A reconstructed vein was judged to be patent not only when the vein was apparently contrast-enhanced but also when the contrast in the vein could be traced all the way to the IVC. On the other hand, an intrahepatic vein was judged to be obstructed when no contrast existed in the vein and the drainage territory of the vein was unevenly contrast-enhanced, suggesting venous congestion. Because the interval between the 2 consecutive CT examinations varied significantly from patient to patient, patency probabilities were calculated as follows. All the reconstructed veins were patent at the end of the transplant operation (day 0). When a patient underwent the first contrast-enhanced CT on postoperative day 7 which revealed that the reconstructed vein was obstructed, the possible timing of the vein obstruction would range from postoperative day 1 to day 7. In this situation, we selected postoperative day 1 as the date of vein obstruction in order to make the strictest judgment. For another example, when a patient underwent the contrast-enhanced CT on postoperative day 30 which revealed the reconstructed vein was intact, but the next CT taken on postoperative day 100 revealed the obstruction of this vein, we selected postoperative day 31 as the date of vein obstruction, again in order to make the strictest judgment. When the reconstructed vein was patent on the last CT, the date of the CT became the censor date for that recipient.
STATISTICS
One-way analysis of variance or Wilcoxon rank sum test was used for comparing numerical variables. Proportions were compared using v 2 test or Fisher's exact test where appropriate. Survival statistics were calculated by a Kaplan-Meier analysis, and patient survival curves were compared using the log-rank test. The censor date was set at November 30, 2015. Statistical significance was defined as having a P value of <0.05. All statistical analyses were performed using the NCSS 9 software package (NCSS LLC., Kaysville, UT).
Results
PATIENT CHARACTERISTICS AND OPERATIVE RESULTS
There were no significant differences in the recipient sex, in the recipient age, in the donor sex, in the donor age, in the background liver disease, in the Model for End-Stage Liver Disease score, in the presence of hepatocellular carcinoma, and in the graft-to-recipient weight ratio among the 3 groups. However, there were significant differences in the cold ischemia time, in the warm ischemia time, in the anhepatic time, in the operative time, and in the estimated intraoperative blood loss. Group 2 patients exhibited the longest cold ischemia time, the longest warm ischemia time, the longest operative time, and the largest estimated intraoperative blood loss, whereas group 3 patients exhibited the longest anhepatic time.
COMPARISON OF THE NUMBERS OF VENOUS ORIFICES
Forty-one grafts in group 1 had 1 orifice of the SRHV only. The other 4 grafts in group 1 had 1 orifice of the SRHV as well as 1 orifice of the IRHV. These 4 orifices of the IRHV were directly anastomosed to the IVC without using any vascular graft. The median numbers of venous orifices in group 2 and 3 were 4 (range, 2-7) and 3 (range, 2-7), respectively. There was no statistically significant difference regarding the numbers of reconstructed venous orifices per a graft between these groups (P 5 0.11, Wilcoxon rank sum test). There were a total of 197 reconstructed venous orifices in 56 grafts in group 2 and 235 orifices in 73 grafts in group 3.
VASCULAR GRAFTS OTHER THAN IJVS USED FOR RECONSTRUCTING MULTIPLE VENOUS ORIFICES
Other vascular grafts used for reconstructing multiple venous orifices together with an IJV graft in group 2 were an EPV graft in 26 cases, an umbilical vein graft in 6 patients, an innominate collateral vessel graft in 2 patients, an ovarian vein graft in 1 patient, an external jugular vein graft in 1 patient, and a saphenous vein graft in 1 patient. In group 3, an EPV graft was used in 58 patients, an inferior mesenteric vein graft in 8 patients, an innominate collateral vein graft in 6 patients, an umbilical vein graft in 5 patients, a saphenous vein graft in 4 patients, and an external jugular vein graft in 1 patient.
COMPARISONS OF THE PATENCY PROBABILITIES OF THE RECONSTRUCTED VEINS BETWEEN GROUP 2 AND GROUP 3
The patency of each reconstructed vein was evaluated by contrast-enhanced CT. Three patients did not undergo any contrast-enhanced CT throughout their postoperative courses. All 3 patients belonged to group 2. The patency probabilities were individually evaluated according to the types of reconstructed veins. As shown in Fig. 2A , the patency probability of the V5s in group 2 was significantly better than that in group 3 (P 5 0.01). The 7-day, 1-month, and 6-month patency probabilities of the V5s were 81.3%, 69.5%, and 69.5% in group 2, and 60.3%, 46.4%, and 44.5% in group 3, respectively. The patency probability of the V8s in group 2 was also significantly better than that in group 3 (P 5 0.04; Fig. 2B ). The 7-day, 1-month, and 6-month patency probabilities of the V8s were 86.8%, 75.4%, and 71.0% in group 2, and 64.6%, 57.8%, and 53.1% in group 3, respectively. The patency probabilities of the IRHVs were almost the same (P 5 0.83; Fig. 2C ). The 7-day, 1-month, and 6-month patency probabilities of the IRHVs were 79.6%, 70.9%, and 67.3% in group 2, and 80.0%, 73.7%, and 71.4% in group 3, respectively.
In order to ascertain whether the patency was influenced by the type of vascular graft that was directly anastomosed to a venous orifice, the comparison was made between the patency probability of the V5s whose orifices were directly anastomosed to an IJV graft and the patency probability of the V5s whose orifices were directly anastomosed to any other vascular graft. The patency probability of the V5s whose orifices were directly anastomosed to an IJV graft was significantly better than that of the V5s whose orifices were directly anastomosed to any other vascular graft (P 5 0.02; Fig. 2D ). The 7-day, 1-month, and 6-month patency probabilities of the V5s whose orifices were directly anastomosed to an IJV graft were 83.2%, 69.4%, and 69.4%, respectively, whereas those of the V5s whose orifices were directly anastomosed to any other vascular graft were 61.4%, 48.9%, and 47.2%, respectively.
COMPLICATIONS RELATED TO THE PROCUREMENT OF AN IJV GRAFT
Four patients in group 3 underwent IJV graft procurement not for the use of reconstructing venous orifices of a RH graft, but for the use of reconstructing the portal vein; therefore, the procurement of an IJV graft was done in a total of 60 patients in the current series (56 in group 2 and 4 in group 3). Hoarseness (temporary vocal cord paralysis) was observed only in 4 (6.7%) patients. The hoarseness spontaneously healed without
Comparisons of the patency probabilities of (A) the V5s, (B) the V8s, (C) the IRHVs between group 2 and group 3, and (D) comparisons of the patency probability of the V5s whose orifices were directly anastomosed to an IJV graft and that of V5s whose orifices were directly anastomosed to any other vascular graft. Because the probability curves reached their steady levels within 1 year, they are depicted up to postoperative month 12.
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any specific treatment. No other complications, such as bleeding or surgical site infection, were observed in the current series.
COMPARISON OF THE POSTOPERATIVE OUTCOMES AMONG THE GROUPS
Septic shock was defined as a state of clinical symptom of sepsis accompanied by rapid deterioration of vital stability, which needed a large-volume fluid resuscitation and catecholamine use. Septic shock was observed in 4 out of 45 (8.9%) patients in group 1, none out of 56 in group 2 (0%), and 6 out of 73 (8.2%) in group 3. There were statistically significant differences not only between the incidences in groups 1 and 2 but also between the incidences in groups 2 and 3 (Fisher's exact test). Three out of the 4 recipients in group 3 who suffered septic shock had the reconstructed veins obstructed (the other 2 recipients had an indeterminable result for the patency of reconstructed veins on contrast-enhanced CT around the events). The septic shock of these 3 recipients was preceded by deterioration of graft function caused by the obstruction of the reconstructed veins. Eight out of 10 patients who suffered septic shock succumbed to inhospital mortality. The 5-year survival probabilities were 77.1%, 90.8%, and 81.6% in groups 1, 2, and 3, respectively. Although there were no statistical significances among those survival curves (P 5 0.07 in group 1 versus group 2; P 5 0.13 in group 2 versus group 3), group 2 patients tended toward higher survival rates.
Discussion
The safety of living liver donors is of paramount importance in LDLT. Since the implementation of our LDLT program in 1996, our strict criteria for a RH graft donor have been as follows: the estimated remnant liver volume is no less than 35% of the total liver volume of the donor, and the MHV trunk is not included in the RH graft except for donors who have an extremely large left hepatic lobe. (5) In the period of the current study, only 4 RH grafts had the MHV trunk. Consequently, most RH grafts in our institute did not have the MHV trunk, instead they did have multiple venous orifices that had to be rigorously reconstructed. In Japan, more than 7000 living donor hepatectomies were performed up until the end of 2014, of which 1 donor succumbed to liver failure after donating a RH graft with the MHV trunk. Although the pathological examination of this donor liver revealed nonalcoholic steatohepatitis, the main cause of the donor's liver failure had to be small remnant liver caused by donating the RH graft together with the MHV trunk. Probably because of this tragedy, most transplant surgeons in Japan avoid using so-called extended RH grafts if possible. The safety of living liver donors should be prioritized far above the complexity accompanied by reconstructing multiple venous orifices on RH grafts resulting from leaving the MHV trunk on the donor side.
Because obstruction of these reconstructed veins on RH grafts often leads to morbid conditions of the recipient caused by a rapid deterioration of liver function, the most reliable means of reconstructing these venous orifices should be selected. As we stated in the introduction, there have been a lot of reported means so far. Each reported means has its own pros and cons. The pros of synthetic vascular grafts are its universal availability, readily prepared for in various lengths and various diameters, whereas the cons are having a relatively rigid vascular wall, having a tendency to become infectious, which may be refractory due to its artificial nature, and having a tendency to become thrombotic, which may require patients to take anticoagulant or antiplatelet drugs. The pros of using EPV grafts are the fact that they are inherently autologous vascular grafts, and therefore, there is no immunological reaction to these vascular grafts, and the fact that by meticulously dissecting the intrahepatic portal branches, EPV grafts of considerable length can be obtained. However, the cons are the fact that obtaining EPV grafts needs to explant the diseased liver first which necessarily leads to the prolongation of anhepatic time; the fact that there is a fear of disseminating cancer cells when a diseased cirrhotic liver harbors hepatocellular carcinoma; and the fact that EPV grafts in cirrhotic livers occasionally lose their flexibility too much to be used as vascular grafts. The pros of cryopreserved veins are the availability in various lengths and diameters, although its use is limited to specific institutions (our institution does not have such a tissue bank), and its biological nature although its tunica intima is injured to some extent by cold storage, freezing, and thawing processes. One of the cons of cryopreserved veins is its homologous nature provokes allogeneic immune reaction, which would result in lower longterm patency rates. Furthermore, the most serious problem in using a cryopreserved vein was the possibility of transmitting serious pathogens. The pros of using superficial femoral veins are the fact that they are also autologous vascular grafts and there is no immunological reaction.
The cons are the fact that obtaining superficial femoral veins is sometimes a cumbersome procedure especially for systemically edematous patients due to end-stage liver disease, and the fact that superficial femoral vein grafts have valves in their lumens which jeopardizes free movement of blood.
We believe one of the most important factors in preventing clot formation in reconstructed venous grafts is constant fluctuations of vessel wall produced by fluctuation in intravascular pressure as a result of the contraction and dilation of the right atrium. IJV grafts not only have the best flexibility but also have the most viable vessel wall among the various vascular grafts reported to be used in liver transplantation so far. The superiority of IJV is supported by the higher patency of V5s directly anastomosed to an IJV graft as shown in Fig. 2D .
The major drawback of procuring an IJV graft is an operative scar in the neck. In order to obtain a sufficiently long IJV graft, it is usually necessary to make an approximately 6-cm-long horizontal skin incision above the clavicle or diagonal skin incision along the medial border of the sternocleidomastoid muscle. (3) However, the scar can be hidden by wearing high collar clothing or a scarf. As shown in this article, we believe that the benefits of using an IJV graft surpasses the drawback of having an operative neck scar. Another probable drawback would be blood congestion in the head. When we procure the left-sided IJV, anesthesiologists insert a central venous catheter as well as a Swan-Ganz catheter into the IJV of the other side. As far as we have been aware, there have been no disadvantages that were likely caused by blood congestion. There are many veins including the IJVs which carry venous blood of the head into the superior vena cava. Although the IJV has a large diameter, removing either side of the IJVs would be of little consequence to the LDLT recipient. One noted complication in procuring an IJV graft was temporary vocal cord paralysis, which was found in only 4 out of 60 recipients. This complication might be caused by operative irritation to the vagus nerve adjacent to the IJV. Even if this hypothesis were true, the vocal cord paralysis occurred only temporarily and had no negative longterm impact on the postoperative course.
There were 3 important shortcomings of this study. First, the sizes of reconstructed venous orifices were not completely recorded at the bench surgery. The smaller the size of the reconstructed venous orifice, the more prone they are to occlusion. The reason why the patency rate of the V5 was low compared to those of the V8 and the IRHV may be attributed simply to the small size of the V5 orifices. Second, there might be a few considerable venous orifices which were intentionally sacrificed because of technical difficulty or for other reasons. For example, some outflows might have been kinked after reperfusion resulting in uncontrollable bleeding at the anastomosis, which required detachment of the anastomosis and closure of the venous orifice. In this study, we picked up only the data upon completion of LDLT, which might influence the results of this study. However, the frequency of such an event must be lower in group 2 because an IJV graft has great flexibility, and therefore, the chance of outflow kinking may be low. Third, there might be a historical bias in this study. We had mostly used EPV grafts in the early study period and mostly used IJV grafts in the late period. A cumulative experience might improve patency rates.
Why were the outcomes in group 1 worse than those in group 2? There were no significantly large MHV tributaries in the anterior sector in group 1; consequently, there must have been no serious congestion areas that led to serious graft dysfunction. However, there usually are many small MHV tributaries in the anterior sector that cannot be reconstructed because of the small size; thus, there usually is a considerable congestion area in sum in the anterior sector of such grafts after portal reperfusion. In fact, the intraoperative blood loss in group 2 was significantly more than that in group 1, which meant that the operative aspects of recipients in group 2 were more severe than those in group 1. When a recipient is in severe condition and a right graft is expected to have multiple venous orifices to be reconstructed, a transplant surgeon would choose the most reliable vascular graft for venous reconstruction, in our case, an IJV graft. This fact might be the main reason why the intraoperative blood loss in group 2 was the largest among the groups. Regardless of such severe conditions, group 2 patients experienced, consequently, the best outcomes among the 3 groups, probably as a result of IJV grafts.
Once the territories of the V5s, the V8s, or the IRHVs are congested due to venous obstruction, the portal flow in these territories would change to detrimental retrograde flow because the arterial flow is constantly anterograde due to its high pressure. The noncongested territory would have to receive all the portal flow of the recipient in addition to the retrograde arterial flow from the congested territory, resulting in detrimental graft swelling and then small-forsize graft syndrome, which often leads to intestinal congestion and resultant bacterial translocation. These are the presumed reasons of the increased incidence of septic shock in patients with a congested liver due to the failure of venous reconstruction in the right graft.
In the current study, we used only autologous vessel grafts for reconstructing venous orifices on right grafts. There were no comparisons between the efficiencies of using IJV grafts and synthetic artificial grafts, or using IJV grafts and cryopreserved homologous vessel grafts. However, at present, we have no plans to introduce synthetic artificial grafts for reconstructing venous orifices on right grafts because we experienced several devastating consequences in using such grafts in other digestive surgeries. For example, replacing the IVC with a synthetic artificial graft resulted in erosion of the intestinal wall caused by the constant irritation of the artificial graft, which necessitated removing that graft. Using cryopreserved venous grafts will require some strict institutional regulations. Moreover, if we began using cryopreserved venous grafts in right graft LDLT, these venous grafts would soon be depleted because such donations are limited in Japan. Introducing IJV grafts for reconstructing venous orifices on right grafts is possible for all transplant centers because using IJV grafts is self-sufficient in nature.
In conclusion, the use of IJV grafts led to high patency rates of reconstructed venous orifices on a right graft in LDLT with minimal adverse consequences and therefore resulted in better clinical outcomes.
